Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Doug Soon who wrote (1903)	5/1/1998 12:58:00 PM
From: Perry	Respond to of 9523

Shouldn't Rx data be released today or have I missed it? Thanks, Perry

To: Doug Soon who wrote (1903)	5/1/1998 12:59:00 PM
From: B.REVERE	Read Replies (2) \| Respond to of 9523

Jim Awad on CNBC just took the stock down 2 points on his comments. He is usually talking about hi-tech small cap stocks and I don't believe he follows pfe that closely. He was responding to a caller's request on his opinion of pfe right now. He commented that the stock was a "double" in one year if Viagra comes through with its earnings. However, he thought it was for aggressive owners only at this level and that as a value player, he would not buy it here(113 13/4). Obviously, does not understand the full potential of Viagra's sales to pfe's bottom line. Another small window to buy before the numbers on Monday are released. Later,